Bone health after age 50 deserves active attention in a way that it rarely receives before a fracture or a concerning DEXA result focuses the mind. The fifth decade is the period when several converging factors begin to erode the skeletal reserve accumulated in youth: the menopausal transition in women triggers accelerated oestrogen-deficient bone loss; age-related increases in bone resorption relative to formation begin in both sexes; and lifestyle factors accumulated over decades — physical activity level, dietary patterns, smoking history, alcohol use — begin to register more clearly in bone density measurements. The good news is that the actions taken at 50, 55, and 60 have a demonstrably larger impact on fracture risk ten and twenty years later than waiting until a fracture occurs. This guide focuses specifically on what changes in bone biology after 50, what assessments are appropriate, and what actions — lifestyle, nutritional, and clinical — are most impactful in this decade.
What Changes in Bone After 50
Bone is continuously remodelled throughout life — osteoclasts resorb old or damaged bone, and osteoblasts form new bone in its place. In young adults, this process is roughly balanced, with formation keeping pace with resorption. Two major changes shift this balance toward net loss after 50:
Oestrogen deficiency (women): At the menopause, falling oestrogen removes the principal restraint on osteoclast activity. In the first decade after the final menstrual period, bone mineral density falls at 2–3% per year at the spine — a rate that can shift T-scores from the normal range to the osteoporosis threshold within a decade in women with borderline starting values. The menopausal transition typically begins in the late 40s (perimenopause) and is usually complete by the early 50s; bone loss accelerates even before the final period, during the perimenopausal years of declining oestrogen. Women who have early or surgical menopause face an earlier and potentially longer window of accelerated loss. Full detail on this transition is in our guide to osteoporosis in women after menopause.
Age-related factors (both sexes): Alongside the sex hormone changes, several age-related processes accelerate bone loss from the early 50s. Declining intestinal calcium absorption efficiency requires higher dietary calcium to maintain the same net absorbed amount. Lower renal 1α-hydroxylase activity reduces vitamin D activation, impairing calcium absorption further. A gradual shift in the bone remodelling cycle toward net resorption occurs even in the absence of sex hormone deficiency as ageing reduces osteoblast number and activity relative to osteoclasts. In men, the equivalent of menopause does not exist, but gradual testosterone and oestradiol decline from the 30s onwards compounds to produce meaningful bone loss by the mid-50s and beyond. Secondary hyperparathyroidism — elevated PTH driven by inadequate calcium absorption — accelerates cortical bone loss at the hip in particular, contributing to the age-related rise in hip fracture rates from the 60s onward.
Why this decade matters: Peak bone mass — the maximum skeletal density achieved in the late 20s to early 30s — is set by the time most people reach 50. It cannot be substantially increased after this point. What can be influenced is the rate at which it is lost. A 50-year-old with above-average peak bone mass who loses 1% per year is in a very different position at 70 than a 50-year-old with below-average peak bone mass who loses 2% per year — even if both start with the same T-score. Actions at 50 compound over the following two decades in exactly the same way that inaction does.
Risk Assessment at 50
The mid-50s is an appropriate time for proactive fracture risk assessment — before a fracture, not after. NICE guidance recommends FRAX assessment (with or without DEXA) for all women aged 65 and over, and for women aged 50–64 with one or more risk factors. In practice, a 50-year-old with one or more of the following should discuss fracture risk assessment with their GP:
- Early or surgical menopause (before age 45)
- Family history of hip fracture in a parent
- Prior fragility fracture (even a wrist fracture from a minor fall)
- Long-term glucocorticoid use (any dose for more than 3 months)
- Low body weight (BMI below 19)
- Current smoking
- Alcohol intake above 14 units per week
- Medical conditions associated with bone loss (rheumatoid arthritis, coeliac disease, inflammatory bowel disease, hyperparathyroidism)
The FRAX tool combines these factors (with or without a BMD input) to estimate 10-year major fracture probability. FRAX is a validated clinical tool developed by the University of Sheffield and endorsed by WHO — it uses age, sex, BMI, clinical risk factors, and optionally femoral neck BMD to calculate percentage probability of major osteoporotic fracture (spine, hip, wrist, or shoulder) and of hip fracture specifically over the next decade. DEXA bone density testing is then recommended if the FRAX score is above the age-appropriate assessment threshold. More on FRAX and DEXA is in our guide to osteoporosis risk factors and our guide to bone density tests: what to expect.
Conditions That Accelerate Bone Loss After 50
In both men and women over 50, a number of underlying medical conditions can accelerate bone loss beyond the rate expected from age and hormonal changes alone. Identifying and managing these secondary causes is one of the most clinically important — and frequently overlooked — aspects of bone health assessment in this age group.
Coeliac disease impairs calcium and vitamin D absorption in the small intestine; many adults are diagnosed incidentally in their 50s or 60s, by which point years of malabsorption may have reduced bone density significantly. Following a strict gluten-free diet reverses malabsorption and halts secondary bone loss, though BMD gains after diagnosis are typically modest and take years.
Inflammatory conditions — including rheumatoid arthritis, inflammatory bowel disease (Crohn’s and ulcerative colitis), and systemic lupus erythematosus — drive bone loss through both the direct effect of inflammatory cytokines on osteoclast activity and the glucocorticoid treatments used to manage them. Glucocorticoid-induced osteoporosis is the most common form of secondary osteoporosis and should prompt routine bone health monitoring in any patient on long-term corticosteroid therapy. NICE guidelines recommend bone protection therapy (bisphosphonates) for most adults on systemic glucocorticoids for three months or longer.
Hyperparathyroidism — primary (an overactive parathyroid gland) or secondary (driven by vitamin D deficiency or chronic kidney disease) — elevates PTH, which drives osteoclast activity and increases cortical bone resorption at sites like the wrist and femoral neck. Primary hyperparathyroidism is often diagnosed incidentally on a routine blood calcium test; bone density testing is standard in its investigation and management.
Type 2 diabetes is associated with increased fracture risk despite normal or above-normal BMD readings. The mechanism involves impaired bone quality — reduced collagen cross-linking and accumulation of advanced glycation end-products in the bone matrix — rather than low density, meaning standard DEXA-based FRAX may underestimate fracture risk in people with type 2 diabetes. Our guide to magnesium and bone health covers the magnesium-T2DM-bone connection, as magnesium deficiency is common in type 2 diabetes and compounds the fracture risk.
Nutrition After 50
The three nutritional pillars of bone health become more important — not less — after 50, because absorption efficiency declines and the consequences of deficiency accumulate more rapidly:
Calcium: Adults over 50 should ensure total calcium intake of 700–1,200 mg/day from diet (preferred) and supplementation if needed. Intestinal calcium absorption efficiency declines with age and with oestrogen deficiency, meaning the same dietary calcium intake delivers less absorbed calcium than it did in younger years. Our guide to calcium and bone health covers dietary sources and supplementation guidance in detail, including the cardiovascular concerns around high-dose calcium supplements.
Vitamin D: Supplementation of 400–800 IU/day is recommended for adults over 50 year-round, as skin synthesis efficiency declines with age and many adults spend insufficient time outdoors for adequate sun-based synthesis. Our guide to vitamin D and bone health covers the evidence for supplementation doses, the 25-OHD testing threshold, and the vitamin D–calcium interdependency.
Protein: Adults over 50 should aim for 1.0–1.2 g/kg/day to support both collagen matrix maintenance and muscle preservation. The muscle-bone connection is particularly important after 50: declining muscle mass (sarcopenia) reduces the mechanical loading stimulus for bone maintenance and increases falls risk. Our guide to protein and bone strength covers the evidence for protein requirements and the muscle-bone interdependency.
Vitamin K2 is increasingly recognised as a fourth key nutritional element for bone health after 50. MK-7 (menaquinone-7), found in fermented foods and available as a supplement, activates osteocalcin — the protein that binds calcium into the bone matrix. Low vitamin K status in postmenopausal women is associated with lower BMD and higher hip fracture risk in observational studies. Our guide to vitamin K and bone health covers the evidence and supplementation guidance.
Exercise After 50
Exercise is the most powerful non-pharmacological stimulus for maintaining bone density after 50. Two exercise types are specifically bone-relevant:
Weight-bearing aerobic exercise — activity performed on the feet against gravity. Walking, brisk walking, jogging, hiking, dancing, tennis, and low-impact aerobics all qualify. The impact forces transmitted through the skeleton during these activities stimulate osteoblast activity at weight-bearing skeletal sites including the hip, spine, and femur. Swimming and cycling, while excellent for cardiovascular health, are non-weight-bearing and provide minimal bone stimulus. Higher-impact activities (jogging, jumping, dancing) produce greater bone stimulus than low-impact walking but need to be matched to individual fitness level and joint health.
Progressive resistance training — strength training with weights, resistance bands, or bodyweight exercises. Muscle contraction during resistance training applies greater forces to bone than weight-bearing aerobic exercise alone. The critical element is progressive overload: continuing to increase the challenge over time rather than repeating the same routine indefinitely. Two to three sessions per week of resistance training, targeting major muscle groups (legs, hips, back, shoulders), provides measurable BMD maintenance benefit at the hip and spine in both men and postmenopausal women. Meta-analyses of resistance training in postmenopausal women show average BMD preservation of 1–2% at the spine and hip over 12–24 months compared to non-exercising controls.
The optimal programme for bone health after 50 combines both: 150 minutes per week of weight-bearing aerobic activity plus 2–3 sessions of progressive resistance training. Balance training — yoga, tai chi, and dedicated balance exercises — adds falls prevention benefit and becomes increasingly important from the 60s onward. Starting exercise in the 50s, before bone loss has progressed significantly, provides the greatest long-term benefit.
Hormone Replacement Therapy at 50
For women in their early to mid-50s who have menopausal symptoms and osteoporosis risk factors, HRT deserves specific consideration as both a symptom management and bone protection strategy. NICE guidance (updated 2024) takes a more favourable view of HRT in women under 60 — the risk-benefit balance in symptom-having women under 60 is generally considered clearly positive for most. For bone protection specifically, oestrogen-containing HRT suppresses the oestrogen-deficient osteoclast activation that drives postmenopausal bone loss, maintaining BMD at near-premenopausal levels for the duration of use.
The decision about HRT is individual and should involve a GP or specialist menopause review. Women with early or surgical menopause (before age 45) should specifically discuss HRT with their GP, as NICE guidance recommends HRT until at least the natural menopause age for these women — the bone and cardiovascular benefits in this age group strongly outweigh the risks. When HRT is eventually stopped, bone loss resumes; a DEXA scan at that point helps determine whether bisphosphonate therapy is needed to protect the BMD preserved during HRT use.
Frequently Asked Questions
Should I get a bone density test at 50?
NICE guidance recommends FRAX risk assessment for all women aged 65 and over, and for women aged 50–64 with one or more clinical risk factors including early menopause, family history of hip fracture, prior fragility fracture, long-term glucocorticoid use, low BMI, smoking, alcohol excess, or conditions like coeliac disease and rheumatoid arthritis. A 50-year-old with one or more of these risk factors should discuss FRAX assessment with their GP. If FRAX indicates elevated 10-year fracture probability above the age-appropriate threshold, DEXA bone density testing is then recommended. Most 50-year-olds without risk factors will not qualify for routine DEXA under NHS criteria, but FRAX provides valuable baseline risk information regardless.
How fast do you lose bone density after 50?
The rate varies substantially depending on whether you are a woman entering the menopause. In women, the first 5–10 years after the final menstrual period are the period of fastest loss — approximately 2–3% of spinal BMD per year in the acute postmenopausal phase, then slowing to approximately 1% per year. Men lose bone at a slower, more gradual rate — typically 0.5–1% per year after 50, with no equivalent of the acute menopausal acceleration. Individual variation is wide: women who start menopause with higher peak bone mass, have natural rather than early or surgical menopause, exercise regularly, and have adequate calcium and vitamin D lose less bone and may never reach the osteoporosis threshold despite decades of postmenopausal bone loss.
Can you build bone density after 50?
Modest increases in BMD are possible in the 50s through progressive resistance training and optimisation of calcium, vitamin D, and protein. Studies of resistance training in early postmenopausal women show BMD improvements of 1–3% at the hip and spine over one to two years. These gains are modest compared to the accelerated postmenopausal bone loss, but meaningful — and resistance training also builds muscle, improving falls prevention. Pharmacological treatments (bisphosphonates, denosumab, teriparatide) produce larger BMD gains than exercise or nutrition alone and are indicated when fracture risk is above the treatment threshold. The more realistic framing for most 50-year-olds is not building large amounts of new bone, but slowing the rate of loss — which has a substantial cumulative effect on fracture risk over the following decades.
What exercise is best for bone health after 50?
The combination of weight-bearing aerobic exercise and progressive resistance training provides the best bone stimulus. Weight-bearing activity (brisk walking, jogging, tennis, dancing, aerobics) applies impact loads to the skeleton that stimulate osteoblasts at weight-bearing sites including the hip and spine. Progressive resistance training applies greater muscle-tendon forces to bone and can target specific skeletal sites. Two to three resistance training sessions per week plus 150 minutes of weight-bearing aerobic activity per week is the evidence-supported target. Exercise should be started or increased gradually after 50 to reduce injury risk — a physiotherapist can advise on appropriate starting intensity and progression for individuals with existing joint problems, prior fracture, or low baseline fitness.
Does menopause always cause osteoporosis?
No — menopause causes bone loss, but whether that loss progresses to osteoporosis (T-score below −2.5) depends on starting bone density, the rate of loss, and the presence of additional risk factors. Women who reach menopause with high peak bone mass, have natural menopause in their early 50s, maintain exercise and adequate nutrition through the transition, and have no secondary causes of bone loss may lose significant bone mass without ever reaching the osteoporosis threshold. However, the majority of women experience some degree of bone density reduction in the decade after menopause; for those with additional risk factors, the cumulative effect can progress to osteoporosis and eventually fragility fracture. Proactive risk assessment and, where indicated, treatment — rather than waiting for a fracture — is the clinical approach recommended by NICE.
Is HRT recommended for bone health at 50?
HRT is an effective bone-protective intervention for women under 60 who have menopausal symptoms. NICE guidance (updated 2024) supports HRT in women under 60 with symptoms, noting that the benefit-risk balance is clearly positive for most women in this age group. For bone protection specifically, HRT suppresses the postmenopausal oestrogen-deficient bone loss for as long as it is taken. However, when HRT is stopped, bone loss resumes — HRT provides ongoing protection during use, not lasting benefit after discontinuation. For women who stop HRT in their early to mid-60s, DEXA assessment at that point is appropriate to determine whether bisphosphonate treatment is needed. HRT is not indicated as a standalone bone protection treatment in women over 60 without menopausal symptoms, where bisphosphonates are preferred as first-line therapy.
What vitamins and minerals are most important for bone health after 50?
Calcium, vitamin D, vitamin K2, and magnesium form the core nutritional framework for bone health after 50. Calcium (700–1,200 mg/day) provides the mineral substrate for hydroxyapatite. Vitamin D (400–800 IU/day from supplements, year-round after 50) is essential for intestinal calcium absorption and osteoblast function — deficiency leads to secondary hyperparathyroidism and accelerated cortical bone loss. Vitamin K2, particularly MK-7, activates osteocalcin, the protein that binds calcium into the bone matrix; found in fermented foods and available as a supplement (100–200 µg/day MK-7). Magnesium supports PTH regulation and vitamin D activation, found in nuts, seeds, and leafy greens. Protein (1.0–1.2 g/kg/day) supports collagen synthesis and muscle mass. A bone-focused diet combining dairy, oily fish, eggs, leafy greens, nuts, seeds, and legumes provides most of these needs, with vitamin D supplementation usually necessary year-round after 50.
Summary
Bone health after age 50 is shaped by the convergence of menopausal oestrogen deficiency in women, age-related declines in calcium absorption and vitamin D activation in both sexes, and the accumulated effect of decades of lifestyle choices. Proactive fracture risk assessment using FRAX, ensuring calcium (700–1,200 mg/day), vitamin D (400–800 IU/day), and protein (1.0–1.2 g/kg/day) adequacy, and maintaining both weight-bearing aerobic exercise and resistance training are the most impactful actions available in this decade. Secondary causes of bone loss — coeliac disease, inflammatory conditions, glucocorticoid use, hyperparathyroidism — should be identified and managed. HRT should be specifically discussed for women under 60 with menopausal symptoms and bone health concerns. For those with elevated fracture risk above the NICE intervention threshold, pharmacological treatment (bisphosphonates, denosumab) provides fracture risk reduction that lifestyle measures alone cannot match. Our companion guide to bone health after age 60 covers the next stage of the bone health journey, and our overview of osteoporosis: symptoms, causes, and prevention covers pharmacological treatment options in detail.
Medical disclaimer: This article is for general educational purposes and does not constitute medical advice. Consult a qualified healthcare professional for personalised bone health assessment and management.
References:
NHS. Osteoporosis. nhs.uk. 2023.
NICE CG146. Osteoporosis: assessing the risk of fragility fracture. NICE. 2023.
NICE NG23. Menopause: diagnosis and management. NICE. 2015 (updated 2024).
Royal Osteoporosis Society. Strong, Steady and Straight: expert consensus on physical activity and exercise for osteoporosis. theros.org.uk. 2019.
Compston JE et al. Osteoporosis. The Lancet. 2017.
I had a DEXA scan at 54 after my GP suggested it based on my history — I had a surgical menopause at 42 (ovary removal due to endometriosis) and have been on HRT since then. My T-scores came back as −1.6 at the spine and −1.4 at the hip, which my GP classified as osteopenia. My endocrinologist explained that despite being on HRT throughout my 40s, the early surgical menopause had still resulted in some bone loss — likely because my HRT dose had been relatively conservative and there had been gaps when I stopped and restarted it. She recommended increasing my HRT dose slightly, adding calcium and vitamin D supplementation, and starting resistance training twice a week. She also said that when I eventually stop HRT, I should expect to be assessed for bisphosphonate therapy. The article’s explanation of surgical menopause causing accelerated bone loss and the importance of maintaining HRT without gaps, and the note that DEXA is needed when HRT is stopped, reflects exactly what my endocrinologist told me.
Caroline, your clinical history illustrates an important aspect of surgical menopause and bone health: even with HRT, the combination of very early oestrogen deficiency (age 42), relatively conservative dosing, and gaps in treatment still resulted in meaningful bone loss by your mid-50s. The T-scores at −1.6/−1.4 at 54 are in the osteopenia range but warrant attention given your history — the trajectory over the next decade matters as much as the current value. Your endocrinologist’s approach (optimising HRT, supplementing calcium and vitamin D, and adding resistance training) addresses all three modifiable factors simultaneously, and planning for bisphosphonate assessment when HRT is eventually stopped is the correct clinical pathway. Ensuring consistency in HRT use going forward, without further gaps, will help protect the BMD gain from the dose increase. Martin, the trabecular bone score is an underutilised but clinically important tool in type 2 diabetes management — your GP’s use of TBS-adjusted FRAX is best-practice and not universally applied. The mechanism you describe (advanced glycation end-products in the bone matrix reducing bone quality without reducing BMD) is a genuine diagnostic gap in standard DEXA-based fracture risk assessment for people with type 2 diabetes. The combination of vitamin D supplementation, resistance training, and three-yearly DEXA monitoring is an evidence-consistent approach for your current risk profile. Maintaining good glycaemic control also moderates the AGE accumulation in bone matrix over time, so optimising HbA1c has bone benefits beyond the vascular ones.
I’m a 57-year-old man with type 2 diabetes and was surprised to learn that this increases my fracture risk beyond what a standard DEXA scan might suggest. I had a DEXA at 55 as part of a diabetes review and my T-scores were −0.9 at the spine and −1.1 at the hip — technically normal. But my GP mentioned that in people with type 2 diabetes the bone quality is affected even when density looks normal, which means the standard FRAX calculation tends to underestimate my real fracture risk. He adjusted the FRAX calculation using my TBS (trabecular bone score) which is an additional measurement that can be done from the DEXA scan to assess bone texture and quality. This brought my estimated 10-year major fracture probability into the range where he recommends I take vitamin D supplementation, maintain regular resistance training, and have a repeat DEXA in three years. The article’s mention of type 2 diabetes causing fracture risk through bone quality rather than low BMD, and FRAX potentially underestimating this risk, is something I wish I had read before my first DEXA — it would have helped me understand why my doctor was doing additional calculations.